These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 3050029)
1. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats. Ohlstein EH; Kruse LI; Ezekiel M; Willette RN J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats. Ohlstein EH; Kruse LI; Ezekiel M; Sherman SS; Erickson R; DeWolf WE; Berkowitz BA J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812 [TBL] [Abstract][Full Text] [Related]
3. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats. Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. Hahn RA; Wardell JR; Sarau HM; Ridley PT J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat. Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone. Cavero I; Lefèvre-Borg F; Gomeni R J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851 [TBL] [Abstract][Full Text] [Related]
8. Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dog. Brooks DP; Fredrickson TA; Koster PF; Ruffolo RR Pharmacology; 1991; 43(2):90-5. PubMed ID: 1775514 [TBL] [Abstract][Full Text] [Related]
9. Prolonged central effects of quinpirole on cardiovascular regulation. van den Buuse M; Morton SJ; Cornish JL; Head GA J Pharmacol Exp Ther; 1996 Apr; 277(1):473-83. PubMed ID: 8613956 [TBL] [Abstract][Full Text] [Related]
10. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress. Ishii Y; Mimura C; Homma M J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175 [TBL] [Abstract][Full Text] [Related]
11. Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. Stanley WC; Li B; Bonhaus DW; Johnson LG; Lee K; Porter S; Walker K; Martinez G; Eglen RM; Whiting RL; Hegde SS Br J Pharmacol; 1997 Aug; 121(8):1803-9. PubMed ID: 9283721 [TBL] [Abstract][Full Text] [Related]
12. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats. Lahlou S Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583 [TBL] [Abstract][Full Text] [Related]
13. Effect of dopamine beta-hydroxylase inhibition on systemic hemodynamics in conscious, spontaneously hypertensive rats. Gellai M; DeWolf RE; Ruffolo RR Pharmacology; 1990; 41(2):82-90. PubMed ID: 2263673 [TBL] [Abstract][Full Text] [Related]
14. Central and peripheral cardiovascular effects of beta-endorphin in normotensive and spontaneously hypertensive rats and in rats rendered hypertensive by deoxycorticosterone acetate administration. Rossi F; Lampa E; Berrino L; Di Giaimo A; Marmo E Res Commun Chem Pathol Pharmacol; 1987 Feb; 55(2):181-92. PubMed ID: 2950576 [TBL] [Abstract][Full Text] [Related]
16. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Anderson IK; Drew GM Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. Ishii R; Tagawa T; Ishida T; Naruse T Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats. Waeber B; Gavras H; Gavras I; Chao P; Kohlman O; Bresnahan MR; Brunner HR; Vaughan D J Pharmacol Exp Ther; 1982 Nov; 223(2):510-5. PubMed ID: 6752375 [TBL] [Abstract][Full Text] [Related]
20. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats. Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]